Wilson Sonsini - ECP

insight detail

Firm Advises Oxbotica on $140 Million Series C Financing

  • 01/12/23
  • Client Highlights
  • Biotech
  • Mobility
  • Software

On January 11, 2023, autonomous vehicle software maker Oxbotica announced that it has raised $140 million in a Series C financing. With this round of financing, Oxbotica has raised approximately $225 million to date. Wilson Sonsini Goodrich & Rosati advised Oxbotica on this transaction and also advised the company on its $47 million Series B investment in January 2021.

The investment includes backing from financial and strategic partners in North America, EMEA and APAC, including new investors such as Aioi Nissay Dowa Insurance Co., Ltd and ENEOS Innovation Partners. Current Oxbotica shareholders including bp ventures, BGF, Halma, Hostplus, Kiko Ventures (IP Group), Ocado Group, Tencent, Venture Science and ZF, amongst others, are also re-investing.

The proceeds will be used to help expand the company’s presence in North America, EMEA and APAC, and to accelerate the deployment of its autonomy operating system where there is an urgent need and the potential to scale, such as agriculture, airports, energy, goods delivery, mining, and shared passenger transportation.

The Wilson Sonsini team that advised Oxbotica on the transaction includes:

Beau Buffier
Adrian Broderick
Michael Labriola
Mike Casey
Stephen Heifetz
Sean Semmler
Jane Trueper
Jose Campos
Rashad Mohammed
Betty Rosenbaum
Jahna Hartwig

For more information, please see Oxbotica’s press release.

ECP Attorneys:

Copyright © 2023 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.

We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content. For more information or to opt-out, visit our privacy policy.